Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibition.
Li H, Furusawa T, Cavero R, Xiao Y, Chari R, Wu X, Sun D, Hartmann O, Dhall A, Holewinski R, Andresson T, Karim B, Villamor-Payà M, Gallardo D, Day CP, Pal LR, Nair NU, Ruppin E, Aladjem MI, Pommier Y, Diefenbacher ME, Lim JM, Levine RL, Stracker TH, Weyemi U.
Li H, et al. Among authors: furusawa t.
Redox Biol. 2025 Jan 19;80:103503. doi: 10.1016/j.redox.2025.103503. Online ahead of print.
Redox Biol. 2025.
PMID: 39854937